DIRAS3 and breast cancer: For example, in ovarian and breast cancers DIRAS3 has been found to inhibit cell migration, induce autophagy and increase sensitivity to chemotherapy (Lu and Bast Jr 2013; Lu 2014; Washington et al. 2015; Zou et al. 2011).